These agonists are primarily used to manage type 2 diabetes by enhancing insulin secretion and inhibiting glucagon release, thereby lowering blood sugar levels
Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome
Only TRINITY_DN30692_c0_g2 had an upregulated expression
The starting dose of semaglutide was 0.25 mg/week for 2 weeks, followed by 0.5 mg/week for 2 weeks, escalating to 1.0 mg/week for 12 weeks
All these trials were designed to evaluate the primary outcome of 3-MACE defined as cardiovascular death, nonfatal myocardial infarct, and nonfatal stroke, except for the ELIXA trial of exenatide ER, which included hospitalization for unstable angina as an additional component of the 4-MACE composite outcomes
Multiple peaks or a broad baseline suggest impurities